Study of an experimental injection for chronic hepatitis b
Doctors are testing a new injectable treatment for chronic hepatitis B. This first-in-human study checks the drug's safety and how well it works in people who are already on standard hepatitis B pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who can understand and agree to the study rules.
- You are taking a standard hepatitis B pill (like entecavir or tenofovir) and have been for at least 6 months.
- Your hepatitis B virus level is low (below 90 IU/mL).
- Your liver tests (ALT, AST) are not too high (no more than 2 times the normal upper limit).
- Your kidneys are working well (confirmed by a blood test).
- You do not have severe liver scarring (cirrhosis) or liver failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called AHB-171 for people with chronic hepatitis B who are already stable on standard antiviral therapy. It aims to see if the drug is safe and may help control the virus better.
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests an experimental injection called TVAX-008 for people with chronic hepatitis B who are already on antiviral therapy. It aims to see if it can help control the virus and potentially lead to a functional cure.
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
Hear when a new HBV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.